{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:54:28Z","timestamp":1783569268546,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum. Genet."],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00439-023-02556-y","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T08:02:09Z","timestamp":1681891329000},"page":"1001-1016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations"],"prefix":"10.1007","volume":"142","author":[{"given":"Samareh","family":"Panjeshahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Karimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Movafagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Ahmadabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Alijanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-3794","authenticated-orcid":false,"given":"Mohammad","family":"Miryounesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"issue":"5","key":"2556_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ajhg.2011.04.004","volume":"88","author":"T Arsov","year":"2011","unstructured":"Arsov T, Smith KR, Damiano J, Franceschetti S, Canafoglia L, Bromhead CJ, Andermann E, Vears DF, Cossette P, Rajagopalan S, McDougall A (2011) Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet 88(5):566\u2013573","journal-title":"Am J Hum Genet"},{"key":"2556_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.conb.2021.08.003","volume":"72","author":"JJ Brudvig","year":"2022","unstructured":"Brudvig JJ, Weimer JM (2022) On the cusp of cures: breakthroughs in Batten disease research. Curr Opin Neurobiol 72:48\u201354","journal-title":"Curr Opin Neurobiol"},{"issue":"8","key":"2556_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-013-0366-z","volume":"13","author":"SL Cotman","year":"2013","unstructured":"Cotman SL, Karaa A, Staropoli JF, Sims KB (2013) Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum. Curr Neurol Neurosci Rep 13(8):1\u20131","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"2556_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1080\/15548627.2015.1043077","volume":"11","author":"G Di Fruscio","year":"2015","unstructured":"Di Fruscio G, Schulz A, De Cegli R, Savarese M, Mutarelli M, Parenti G, Banfi S, Braulke T, Nigro V, Ballabio A (2015) Lysoplex: an efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway. Autophagy 11(6):928\u2013938","journal-title":"Autophagy"},{"issue":"4","key":"2556_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/cge.12279","volume":"86","author":"M Faruq","year":"2014","unstructured":"Faruq M, Narang A, Kumari R, Pandey R, Garg A, Behari M, Dash D, Srivastava AK, Mukerji M (2014) Novel mutations in typical and atypical genetic loci through exome sequencing in autosomal recessive cerebellar ataxia families. Clin Genet 86(4):335\u2013341","journal-title":"Clin Genet"},{"key":"2556_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.754045","volume":"12","author":"E Gardner","year":"2021","unstructured":"Gardner E, Mole SE (2021) The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses. Front Neurol 12:754045","journal-title":"Front Neurol"},{"issue":"1","key":"2556_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0414-2","volume":"11","author":"RD Geraets","year":"2016","unstructured":"Geraets RD, Hastings ML, Kielian T, Pearce DA, Weimer JM (2016) Moving towards effective therapeutic strategies for neuronal ceroid lipofuscinosis. Orphanet J Rare Dis 11(1):1\u20133","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2556_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","volume":"62","author":"M Haltia","year":"2003","unstructured":"Haltia M (2003) The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 62(1):1\u20133","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"2556_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","volume":"1832","author":"M Haltia","year":"2013","unstructured":"Haltia M, Goebel HH (2013) The neuronal ceroid-lipofuscinoses: a historical introduction. Biochim Biophys Acta (BBA) Mol Basis Dis 1832(11):1795\u20131800","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"11","key":"2556_CR10","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.bbadis.2013.05.026","volume":"1832","author":"JA Hawkins-Salsbury","year":"2013","unstructured":"Hawkins-Salsbury JA, Cooper JD, Sands MS (2013) Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease). Biochim Biophys Acta (BBA) Mol Basis Dis 1832(11):1906\u20131909","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"10","key":"2556_CR11","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.3390\/ijms23105729","volume":"23","author":"K Kamini\u00f3w","year":"2022","unstructured":"Kamini\u00f3w K, Kozak S, Paprocka J (2022) Recent insight into the genetic basis, clinical features, and diagnostic methods for neuronal ceroid lipofuscinosis. Int J Mol Sci 23(10):5729","journal-title":"Int J Mol Sci"},{"issue":"D1","key":"2556_CR12","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","volume":"49","author":"S K\u00f6hler","year":"2021","unstructured":"K\u00f6hler S, Gargano M, Matentzoglu N, Carmody LC, Lewis-Smith D, Vasilevsky NA, Danis D, Balagura G, Baynam G, Brower AM, Callahan TJ (2021) The human phenotype ontology in 2021. Nucleic Acids Res 49(D1):D1207\u2013D1217","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2556_CR13","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.bbadis.2013.01.019","volume":"1832","author":"K Kollmann","year":"2013","unstructured":"Kollmann K, Uusi-Rauva K, Scifo E, Tyynel\u00e4 J, Jalanko A, Braulke T (2013) Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta (BBA) Mol Basis Dis 1832(11):1866\u20131881","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"3","key":"2556_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/brain\/awn366","volume":"132","author":"M Kousi","year":"2009","unstructured":"Kousi M, Siintola E, Dvorakova L, Vlaskova H, Turnbull J, Topcu M, Yuksel D, Gokben S, Minassian BA, Elleder M, Mole SE (2009) Mutations in CLN7\/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Brain 132(3):810\u2013819","journal-title":"Brain"},{"issue":"1","key":"2556_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/humu.21624","volume":"33","author":"M Kousi","year":"2012","unstructured":"Kousi M, Lehesjoki AE, Mole SE (2012) Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 33(1):42\u201363","journal-title":"Hum Mutat"},{"issue":"5","key":"2556_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0883073819895694","volume":"35","author":"G Lewis","year":"2020","unstructured":"Lewis G, Morrill AM, Conway-Allen SL, Kim B (2020) Review of cerliponase alfa: recombinant human enzyme replacement therapy for late-infantile neuronal ceroid lipofuscinosis type 2. J Child Neurol 35(5):348\u2013353","journal-title":"J Child Neurol"},{"issue":"5","key":"2556_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics 26(5):589\u2013595","journal-title":"Bioinformatics"},{"issue":"16","key":"2556_CR18","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al (2009) The sequence alignment\/map format and SAMtools. Bioinformatics 25(16):2078\u20132079","journal-title":"Bioinformatics"},{"issue":"11","key":"2556_CR19","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s40265-017-0771-8","volume":"77","author":"A Markham","year":"2017","unstructured":"Markham A (2017) Cerliponase alfa: first global approval. Drugs 77(11):1247\u20131249","journal-title":"Drugs"},{"issue":"9","key":"2556_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297\u20131303","journal-title":"Genome Res"},{"issue":"9","key":"2556_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/0883073813494268","volume":"28","author":"JW Mink","year":"2013","unstructured":"Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM (2013) Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol 28(9):1101\u20131105","journal-title":"J Child Neurol"},{"issue":"1","key":"2556_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1750-3639.2004.tb00500.x","volume":"14","author":"SE Mole","year":"2004","unstructured":"Mole SE (2004) The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol 14(1):70\u201376","journal-title":"Brain Pathol"},{"issue":"10","key":"2556_CR23","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","volume":"1852","author":"SE Mole","year":"2015","unstructured":"Mole SE, Cotman SL (2015) Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta (BBA) Mol Basis Dis 1852(10):2237\u20132241","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"3","key":"2556_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole SE, Williams RE, Goebel HH (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6(3):107\u2013126","journal-title":"Neurogenetics"},{"key":"2556_CR25","volume-title":"The neuronal ceroid lipofuscinoses (Batten disease)","year":"2011","unstructured":"Mole S, Williams R, Goebel H (eds) (2011). Oxford University Press, Oxford"},{"issue":"1","key":"2556_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0300-6","volume":"14","author":"AB Mukherjee","year":"2019","unstructured":"Mukherjee AB, Appu AP, Sadhukhan T, Casey S, Mondal A, Zhang Z, Bagh MB (2019) Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses. Mol Neurodegener 14(1):1\u201323","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2556_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1750-8606.2007.00004.x","volume":"1","author":"CA Nelson","year":"2007","unstructured":"Nelson CA (2007) A neurobiological perspective on early human deprivation. Child Dev Perspect 1(1):13\u201318","journal-title":"Child Dev Perspect"},{"issue":"S2","key":"2556_CR28","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1684\/epd.2016.0844","volume":"18","author":"DA Nita","year":"2016","unstructured":"Nita DA, Mole SE, Minassian BA (2016) Neuronal ceroid lipofuscinoses. Epileptic Disord 18(S2):S73\u2013S88","journal-title":"Epileptic Disord"},{"issue":"2","key":"2556_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ajhg.2011.07.003","volume":"89","author":"L Noskov\u00e1","year":"2011","unstructured":"Noskov\u00e1 L, Str\u00e1neck\u00fd V, Hartmannov\u00e1 H, P\u0159istoupilov\u00e1 A, Bare\u0161ov\u00e1 V, Iv\u00e1nek R, H\u016flkov\u00e1 H, Jahnov\u00e1 H, van der Zee J, Staropoli JF, Sims KB (2011) Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am J Hum Genet 89(2):241\u2013252","journal-title":"Am J Hum Genet"},{"issue":"12","key":"2556_CR30","first-page":"2146","volume":"40","author":"T Roine","year":"2019","unstructured":"Roine T, Roine U, Tokola A, Balk MH, Mannerkoski M, \u00c5berg L, L\u00f6nnqvist T, Autti T (2019) Topological alterations of the structural brain connectivity network in children with juvenile neuronal ceroid lipofuscinosis. Am J Neuroradiol 40(12):2146\u20132153","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"2556_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","volume":"10","author":"P Santavuori","year":"1988","unstructured":"Santavuori P (1988) Neuronal ceroid-lipofuscinoses in childhood. Brain Dev 10(2):80\u201383","journal-title":"Brain Dev"},{"issue":"2","key":"2556_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1006\/bbrc.1998.8484","volume":"245","author":"FM Santorelli","year":"1998","unstructured":"Santorelli FM, Bertini E, Petruzzella V, Di Capua M, Calvieri S, Gasparini P, Zeviani M (1998) A novel insertion mutation (A169i) in the CLN1 gene is associated with infantile neuronal ceroid lipofuscinosis in an Italian patient. Biochem Biophys Res Commun 245(2):519\u2013522","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"2556_CR33","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz A, Ajayi T, Specchio N, de Los RE, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlsch\u00fctter A (2018) Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med 378(20):1898\u20131907","journal-title":"N Engl J Med"},{"issue":"4","key":"2556_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2005.12.006","volume":"27","author":"SS Seehafer","year":"2006","unstructured":"Seehafer SS, Pearce DA (2006) You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol Aging 27(4):576\u2013588","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2556_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/humu.10227","volume":"22","author":"JD Sharp","year":"2003","unstructured":"Sharp JD, Wheeler RB, Parker KA, Gardiner RM, Williams RE, Mole SE (2003) Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis. Hum Mutat 22(1):35\u201342","journal-title":"Hum Mutat"},{"key":"2556_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.811686","volume":"13","author":"A Simonati","year":"2022","unstructured":"Simonati A, Williams RE (2022) Neuronal ceroid lipofuscinosis: the multifaceted approach to the clinical issues, an overview. Front Neurol 13:811686","journal-title":"Front Neurol"},{"issue":"5333","key":"2556_CR37","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","volume":"277","author":"DE Sleat","year":"1997","unstructured":"Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277(5333):1802\u20131805","journal-title":"Science"},{"issue":"2","key":"2556_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.gene.2016.08.031","volume":"593","author":"DE Sleat","year":"2016","unstructured":"Sleat DE, Gedvilaite E, Zhang Y, Lobel P, Xing J (2016) Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis. Gene 593(2):284\u2013291","journal-title":"Gene"},{"issue":"4","key":"2556_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ana.24251","volume":"76","author":"S Srivastava","year":"2014","unstructured":"Srivastava S, Cohen JS, Vernon H, Bara\u00f1ano K, McClellan R, Jamal L, Naidu S, Fatemi A (2014) Clinical whole exome sequencing in child neurology practice. Ann Neurol 76(4):473\u2013483","journal-title":"Ann Neurol"},{"issue":"10","key":"2556_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","volume":"85","author":"T Tomson","year":"2015","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, EURAP Study Group (2015) Dose-dependent teratogenicity of valproate in mono-and polytherapy: an observational study. Neurology 85(10):866\u2013872","journal-title":"Neurology"},{"issue":"1","key":"2556_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/mgg3.262","volume":"5","author":"D Trujillano","year":"2017","unstructured":"Trujillano D, Oprea GE, Schmitz Y, Bertoli-Avella AM, Abou Jamra R, Rolfs A (2017) A comprehensive global genotype\u2013phenotype database for rare diseases. Mol Genet Genomic Med 5(1):66\u201375","journal-title":"Mol Genet Genomic Med"},{"issue":"11","key":"2556_CR42","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","volume":"1832","author":"V Warrier","year":"2013","unstructured":"Warrier V, Vieira M, Mole SE (2013) Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. Biochim Biophys Acta (BBA) Mol Basis Dis 1832(11):1827\u20131830","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"issue":"2","key":"2556_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","volume":"79","author":"RE Williams","year":"2012","unstructured":"Williams RE, Mole SE (2012) New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79(2):183\u2013191","journal-title":"Neurology"},{"issue":"4","key":"2556_CR44","first-page":"373","volume":"79","author":"World Medical Association","year":"2001","unstructured":"World Medical Association (2001) World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ 79(4):373","journal-title":"Bull World Health Organ"},{"issue":"10","key":"2556_CR45","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10072-015-2272-4","volume":"36","author":"F Yu","year":"2015","unstructured":"Yu F, Liu XM, Chen YH, Zhang SQ, Wang K (2015) A novel CLN2\/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis. Neurol Sci 36(10):1917\u20131919","journal-title":"Neurol Sci"},{"issue":"4","key":"2556_CR46","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1542\/peds.44.4.570","volume":"44","author":"W Zeman","year":"1969","unstructured":"Zeman W, Dyken P (1969) Neuronal ceroid-lipofuscinosis (Batten\u2019s disease): relationship to amaurotic family idiocy? Pediatrics 44(4):570\u2013583","journal-title":"Pediatrics"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-023-02556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00439-023-02556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-023-02556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:08:30Z","timestamp":1692839310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00439-023-02556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1007\/s00439-023-02556-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2514013\/v1","asserted-by":"object"}]},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"28 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mrs. Samareh Panjeshahi declares that she has no conflict of interest. Professor Parvaneh Karimzadeh declares that she has no conflict of interest. Professor Abolfazl Movafagh declares that he has no conflict of interest. Professor Farzad Ahmadabadi declares that he has no conflict of interest. Dr. Elham Rahimian declares that she has no conflict of interest. Miss. Sahar Alijanpour declares that she has no conflict of interest. Professor Mohammad Miryounesi declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee of the Institutional Review Board (IRB), with the approval code of IR.SBMU.MSP.REC.1400. 250 and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}